Maintenance therapy with infliximab or vedolizumab in inflammatory bowel disease is not associated with increased SARS-CoV-2 seroprevalence: UK experience in the 2020 pandemic
Colleen G C McGregor, Alex Adams, Ross Sadler, Carolina V Arancibia-Cárcamo, Rebecca Palmer, Tim Ambrose, Oliver Brain, Alissa Walsh, Paul Klenerman, Simon Travis, Nicholas M Croft, James O Lindsay, Jack Satsangi
doi: https://doi.org/10.1101/2020.12.12.20247841
Colleen G C McGregor
1Translational Gastroenterology Unit, NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK
Alex Adams
1Translational Gastroenterology Unit, NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK
Ross Sadler
2Department of Laboratory Immunology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK
Carolina V Arancibia-Cárcamo
1Translational Gastroenterology Unit, NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK
Rebecca Palmer
1Translational Gastroenterology Unit, NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK
Tim Ambrose
1Translational Gastroenterology Unit, NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK
Oliver Brain
1Translational Gastroenterology Unit, NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK
Alissa Walsh
1Translational Gastroenterology Unit, NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK
Paul Klenerman
1Translational Gastroenterology Unit, NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK
Simon Travis
1Translational Gastroenterology Unit, NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK
Nicholas M Croft
3Centre for Immunobiology, Blizard Institute, Queen Mary University of London, UK
4Departments of Gastroenterology and Paediatric Gastroenterology, Royal London Hospital, Barts Health NHS Trust, London, UK
James O Lindsay
3Centre for Immunobiology, Blizard Institute, Queen Mary University of London, UK
4Departments of Gastroenterology and Paediatric Gastroenterology, Royal London Hospital, Barts Health NHS Trust, London, UK
Jack Satsangi
1Translational Gastroenterology Unit, NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK
Article usage
Posted December 15, 2020.
Maintenance therapy with infliximab or vedolizumab in inflammatory bowel disease is not associated with increased SARS-CoV-2 seroprevalence: UK experience in the 2020 pandemic
Colleen G C McGregor, Alex Adams, Ross Sadler, Carolina V Arancibia-Cárcamo, Rebecca Palmer, Tim Ambrose, Oliver Brain, Alissa Walsh, Paul Klenerman, Simon Travis, Nicholas M Croft, James O Lindsay, Jack Satsangi
medRxiv 2020.12.12.20247841; doi: https://doi.org/10.1101/2020.12.12.20247841
Maintenance therapy with infliximab or vedolizumab in inflammatory bowel disease is not associated with increased SARS-CoV-2 seroprevalence: UK experience in the 2020 pandemic
Colleen G C McGregor, Alex Adams, Ross Sadler, Carolina V Arancibia-Cárcamo, Rebecca Palmer, Tim Ambrose, Oliver Brain, Alissa Walsh, Paul Klenerman, Simon Travis, Nicholas M Croft, James O Lindsay, Jack Satsangi
medRxiv 2020.12.12.20247841; doi: https://doi.org/10.1101/2020.12.12.20247841
Subject Area
Subject Areas
- Addiction Medicine (313)
- Allergy and Immunology (616)
- Anesthesia (158)
- Cardiovascular Medicine (2253)
- Dermatology (199)
- Emergency Medicine (368)
- Epidemiology (11542)
- Forensic Medicine (10)
- Gastroenterology (676)
- Genetic and Genomic Medicine (3539)
- Geriatric Medicine (336)
- Health Economics (611)
- Health Informatics (2283)
- Health Policy (909)
- Hematology (333)
- HIV/AIDS (741)
- Medical Education (357)
- Medical Ethics (100)
- Nephrology (385)
- Neurology (3322)
- Nursing (189)
- Nutrition (504)
- Oncology (1747)
- Ophthalmology (521)
- Orthopedics (208)
- Otolaryngology (283)
- Pain Medicine (221)
- Palliative Medicine (66)
- Pathology (434)
- Pediatrics (997)
- Primary Care Research (398)
- Public and Global Health (5966)
- Radiology and Imaging (1213)
- Respiratory Medicine (806)
- Rheumatology (367)
- Sports Medicine (309)
- Surgery (383)
- Toxicology (50)
- Transplantation (169)
- Urology (142)